Current Size: 100%

Publications

Burghuber, OC, Kirchbacher K, Mohn-Staudner A, Hochmair M, Breyer M.-K, Studnicka M, Mueller M. R, Feurstein P, Schrott A, Lamprecht B, Eckmayr J, Renner F, Bolitschek J, Pohl W, Schenk P, Errhalt P, Cerkl P, Baumgartner B, Kneussl M, Hartl S. Results of the Austrian National Lung Cancer Audit. Clinical Medicine Insights: Oncology 2020.
Verberkt CA, van den Beuken-van Everdingen MHJ, Schols JMGA, Hameleers N, Wouters EFM, Janssen DJA. Effect of Sustained-Release Morphine for Refractory Breathlessness in Chronic Obstructive Pulmonary Disease on Health Status: A Randomized Clinical Trial. JAMA internal medicine. 2020 Aug 17:e203134.
Urban MH, Kreibich N, Gleiss A, Funk GC, Hartl S, Burghuber OC. Effects of roflumilast on arterial stiffness in COPD (ELASTIC): A randomized trial [published online ahead of print, 2020 Jul 28]. Respirology. 2020;10.1111/resp.13914.
Perkmann T, Perkmann-Nagele N, Breyer MK, Breyer-Kohansal R, Burghuber OC, Hartl S, Aletaha D, Sieghart D, Quehenberger P, Marculescu R, Mucher P, Strassl R, Wagner OF, Binder CJ, Haslacher H. Side by side comparison of three fully automated SARS-CoV-2 antibody assays with a focus on specificity. Clin Chem. 2020 Aug 10:hvaa198.
Breyer-Kohansal R, Faner R, Breyer MK, Ofenheimer A, Schrott A, Studnicka M, Wouters EFM, Burghuber OC, Hartl S, Agusti A. Factors Associated with Low Lung Function in Different Age Bins in the General Population. Am J Respir Crit Care Med 2020;202(2):292-296.
Ofenheimer A, Breyer-Kohansal R, Hartl S, Burghuber OC, Krach F, Schrott A, Franssen FME, Wouters EFM, Breyer MK. Reference charts for body composition parameters by dual-energy X-ray absorptiometry in European children and adolescents aged 6 to 18 years-Results from the Austrian LEAD (Lung, hEart, sociAl, boDy) cohort. Pediatric obesity 2020; e12695.
Breyer MK, Ofenheimer A, Altziebler J, Hartl S, Burghuber OC, Studnicka M, Purin D, Heinzle C, Drexel H, Franssen FME, Wouters EFM, Harreiter J, Kautzky-Willer A, Breyer-Kohansal R. Marked differences in prediabetes- and diabetes-associated comorbidities between men and women-Epidemiological results from a general population-based cohort aged 6-80 years -The LEAD (Lung, hEart, sociAl, boDy) study. Eur J Clin Invest 2020;(December 2019):1-9.
 
Hartl S, Breyer MK, Burghuber OC, Ofenheimer A, Schrott A, Urban MH, Agusti A, Studnicka M, Wouters EFM, Breyer-Kohansal R. Blood eosinophil count in the general population: typical values and potential confounders. Eur Respir J. 2020;1901874.
 
Ofenheimer A, Breyer-Kohansal R, Hartl S, Burghuber OC, Krach F, Schrott A, Wouters EFM, Franssen FME, Breyer MK. Reference values of body composition parameters and visceral adipose tissue (VAT) by DXA in adults aged 18-81 years-results from the LEAD cohort. Eur J Clin Nutr 2020;i.
 
Breyer-Kohansal R, Hartl S, Breyer MK, Schrott A, Studnicka M, Neunhäuserer D, Fülöp G, Burghuber OC. The European COPD audit: Adherence to guidelines, readmission risk and hospital care for acute exacerbations in Austria. Wien Klin Wochenschr 2019;131(5–6):97–103.
 
Breyer-Kohansal R, Hartl S, Burghuber OC, Urban M, Schrott A, Agusti A, Sigsgaard T, Vogelmeier C, Wouters E, Studnicka M, Breyer MK. The LEAD (Lung, Heart, Social, Body) Study: Objectives, Methodology, and External Validity of the Population-Based Cohort Study. J Epidemiol 2019;29(8):315–24.
 
Buder A, Setinek U, Hochmair MJ, Schwab S, Kirchbacher K, Keck A, Burghuber OC, Pirker R, Filipits M. EGFR Mutations in Cell-free Plasma DNA from Patients with Advanced Lung Adenocarcinoma: Improved Detection by Droplet Digital PCR. Target Oncol 2019;14(2):197–203.
 
Halmos B, Tan E-H, Soo RA, et al. Impact of afatinib dose modification on safety and effectiveness in patients with EGFR mutation-positive advanced NSCLC: Results from a global real-world study (RealGiDo). Lung Cancer 2019;127:103–11.
 
Hochmair MJ, Buder A, Schwab S, et al. Liquid-Biopsy-Based Identification of EGFR T790M Mutation-Mediated Resistance to Afatinib Treatment in Patients with Advanced EGFR Mutation-Positive NSCLC, and Subsequent Response to Osimertinib. Target Oncol 2019;14(1):75–83.
 
Brcic L, Stanzer S, Krenbek D, et al. Immune cell landscape in therapy-naïve squamous cell and adenocarcinomas of the lung. Virchows Arch 2018;472(4):589–98.
 
Buder A, Hochmair MJ, Schwab S, et al. Cell-Free Plasma DNA-Guided Treatment With Osimertinib in Patients With Advanced EGFR-Mutated NSCLC. J Thorac Oncol 2018;13(6):821–30.
 
Camidge DR, Kim HR, Ahn MJ, et al. Brigatinib versus crizotinib in ALK-positive non-small-cell lung cancer. N Engl J Med 2018;379(21):2027–39.
 
Gasser S, Krenbek D, Hochmair M. Fatale immunmediierte organisierende Pneumonie unter Pembrolizumab - Therapie eines pulmonalen Adenokarzinoms. RoFo Fortschritte auf dem Gebiet der Rontgenstrahlen und der Bildgeb Verfahren 2018;190(12):1161–3.
 
Gompelmann D, Shah PL, Valipour A, Herth FJF. Bronchoscopic Thermal Vapor Ablation: Best Practice Recommendations from an Expert Panel on Endoscopic Lung Volume Reduction. Respiration 2018;95(6):1–9.
 
Hochmair M. Medical Treatment Options for Patients with Epidermal Growth Factor Receptor Mutation-Positive Non-Small Cell Lung Cancer Suffering from Brain Metastases and/or Leptomeningeal Disease. Target Oncol 2018;13(3):269–85.
 
Hochmair MJ, Morabito A, Hao D, et al. Sequential treatment with afatinib and osimertinib in patients with EGFR mutation-positive non-small-cell lung cancer: an observational study. Futur Oncol 2018;14(27):2861–74.
 
Hochmair MJ. Correction to: Medical Treatment Options for Patients with Epidermal Growth Factor Receptor Mutation-Positive Non-Small Cell Lung Cancer Suffering from Brain Metastases and/or Leptomeningeal Disease. Target Oncol 2018;13(5):667–667.
 
Horn L, Mansfield AS, Szczȩsna A, et al. First-line atezolizumab plus chemotherapy in extensive-stage small-cell lung cancer. N Engl J Med 2018;379(23):2220–9.
 
Reiger G, Zwick R, Lamprecht B, Kähler C, Burghuber OC, Valipour A. Phenotypes of COPD in an Austrian population: National data from the POPE study. Wien Klin Wochenschr 2018;130(11–12):382–9.
 
Valipour A. Valve therapy in patients with emphysematous type of chronic obstructive pulmonary disease (COPD): from randomized trials to patient selection in clinical practice. J Thorac Dis 2018;10(S23):S2780–96.
 
Valipour A, Asadi S, Pison C, et al. Long-term safety of bilateral targeted lung denervation in patients with COPD. Int J Chron Obstruct Pulmon Dis 2018;Volume 13:2163–72.
Beeh KM, Burgel P-R, Franssen FME, et al. How Do Dual Long-Acting Bronchodilators Prevent Exacerbations of Chronic Obstructive Pulmonary Disease? Am J Respir Crit Care Med 2017;196(2):139–49.
 
Buess M, Schilter D, Schneider T, et al. Treatment of COPD Exacerbation in Switzerland: Results and Recommendations of the European COPD Audit. Respiration 2017;94(4):355–65.
 
Gómez López A, Luján RG, De Pablo Gafas A, et al. First use of Amplatzer device for bronchopleural fistula after lung transplantation. Thorax 2017;668–70.
 
Hochmair MJ, Schwab S, Burghuber OC, Krenbek D, Prosch H. Symptomatic pseudo-progression followed by significant treatment response in two lung cancer patients treated with immunotherapy. Lung Cancer 2017;113:4–6.
 
Koblizek V, Milenkovic B, Barczyk A, et al. Phenotypes of COPD patients with a smoking history in Central and Eastern Europe: the POPE Study. Eur Respir J 2017;49(5):1601446.
 
Lopez-Campos JL, Castro-Acosta A, Pozo-Rodriguez F, Hartl S, Roberts CM. Accuracy of COPD Diagnosis During an Admission: The European Perspective. Chest 2017;151(6):1396–7.
 
Slebos D-J, Shah PL, Herth FJF, Valipour A. Endobronchial Valves for Endoscopic Lung Volume Reduction: Best Practice Recommendations from Expert Panel on Endoscopic Lung Volume Reduction. Respiration 2017;93(2):138–50.
 
Tudoric N, Koblizek V, Miravitlles M, et al. GOLD 2017 on the way to a phenotypic approach? Analysis from the Phenotypes of COPD in Central and Eastern Europe (POPE) Cohort. Eur Respir J 2017;49(4):1602518.
 
Urban M, Eickhoff P, Funk G-C, Burghuber OC, Wolzt M, Valipour A. Increased brachial intima-media thickness is associated with circulating levels of asymmetric dimethylarginine in patients with COPD. Int J Chron Obstruct Pulmon Dis 2017;12:169–76.
 
Gompelmann D, Eberhardt R, Schuhmann M, et al. Lung Volume Reduction with Vapor Ablation in the Presence of Incomplete Fissures: 12-Month Results from the STEP-UP Randomized Controlled Study. Respiration 2016;92(6):397–403.
 
Hartl S, Lopez-Campos JLJL. Readmission in COPD patients: should we consider it a marker of quality of care or a marker of a more severe disease with a worse prognosis? Eur Respir J 2016;48(1):281–2.
 
Hartl S, Lopez-Campos JL, Pozo-Rodriguez F, et al. Risk of death and readmission of hospital-admitted COPD exacerbations: European COPD Audit. Eur Respir J 2016;47(1):113–21.
 
Herth FJF, Valipour A, Shah PL, et al. Segmental volume reduction using thermal vapour ablation in patients with severe emphysema: 6-month results of the multicentre, parallel-group, open-label, randomised controlled STEP-UP trial. Lancet Respir Med 2016;4(3):185–93.
 
Neunhäuserer D, Steidle-Kloc E, Weiss G, et al. Supplemental Oxygen During High-Intensity Exercise Training in Nonhypoxemic Chronic Obstructive Pulmonary Disease. Am J Med 2016;129(11):1185–93.
 
Ruparel M, López-Campos JL, Castro-Acosta A, Hartl S, Pozo-Rodriguez F, Roberts CM. Understanding variation in length of hospital stay for COPD exacerbation: European COPD audit. ERJ Open Res 2016;2(1):00034–2015.
 
Shah PL, Gompelmann D, Valipour A, et al. Thermal vapour ablation to reduce segmental volume in patients with severe emphysema: STEP-UP 12 month results. Lancet Respir Med 2016;4(9):e44–5.
 
Valipour A. Endoscopic valve therapy for emphysema: Patient selection as the Holy Grail to success. Respirology 2016;21(7):1148–9.
 
Valipour A, Slebos D-JJ, Herth FJ, et al. Endobronchial Valve Therapy in Patients with Homogeneous Emphysema. Results from the IMPACT Study. Am J Respir Crit Care Med 2016;194(9):1073–82.
 
Zbozinkova Z, Barczyk A, Tkacova R, et al. POPE study: Rationale and methodology of a study to phenotype patients with COPD in central and Eastern Europe. Int J COPD 2016;11(1):611–22.
 
López-Campos JL, Hartl S, Pozo-Rodriguez F, Roberts CM. Antibiotic Prescription for COPD Exacerbations Admitted to Hospital: European COPD Audit. PLoS One 2015;10(4):e0124374.
 
Potura E, Lindner G, Biesenbach P, et al. An acetate-buffered balanced crystalloid versus 0.9% saline in patients with end-stage renal disease undergoing cadaveric renal transplantation: A prospective randomized controlled trial. Anesth Analg 2015;120(1):123–9.
 
Saleh A, López-Campos JL, Hartl S, Pozo-Rodríguez F, Roberts CM. The Effect of Incidental Consolidation on Management and Outcomes in COPD Exacerbations: Data from the European COPD Audit. PLoS One 2015;10(7):e0134004.
 
Slebos D-JJ, Klooster K, Koegelenberg CFNN, et al. Targeted lung denervation for moderate to severe COPD: a pilot study. Thorax 2015;70(5):411–9.
 
Urban M, Burghuber OC, Dereci C, et al. Tobacco addiction and smoking cessation in Austrian migrants: a cross-sectional study. BMJ Open 2015;5(6):e006510–e006510.
 
Valipour A, Shah PL, Gesierich W, et al. Patterns of Emphysema Heterogeneity. Respiration 2015;90(5):402–11.
 
Breyer M-K, Spruit MA, Hanson CK, et al. Prevalence of Metabolic Syndrome in COPD Patients and Its Consequences. PLoS One 2014;9(6):e98013.
 
Gompelmann D, Herth FJF, Slebos DJ, et al. Pneumothorax following Endobronchial Valve Therapy and Its Impact on Clinical Outcomes in Severe Emphysema. Respiration 2014;87(6):485–91.
 
Köhnlein T, Windisch W, Köhler D, et al. Non-invasive positive pressure ventilation for the treatment of severe stable chronic obstructive pulmonary disease: a prospective, multicentre, randomised, controlled clinical trial. Lancet Respir Med 2014;2(9):698–705.
 
Lindner G, Funk G-C, Leichtle AB, et al. Impact of proton pump inhibitor use on magnesium homoeostasis: a cross-sectional study in a tertiary emergency department. Int J Clin Pract 2014;68(11):1352–7.
 
Lindner G, Doberer D, Schwarz C, Schneeweiss B, Funk G-C. Evaporation of free water causes concentrational alkalosis in vitro. Wien Klin Wochenschr 2014;126(7–8):201–7.
 
Lindner G, Funk GC, Pfortmueller CA, et al. D-dimer to rule out pulmonary embolism in renal insufficiency. Am J Med 2014;127(4):343–7.
 
Lopez-Campos JL, Hartl S, Pozo-Rodriguez F, Roberts CM. Variability of hospital resources for acute care of COPD patients: the European COPD Audit. Eur Respir J 2014;43(3):754–62.
 
Pertl D, Eisenmann A, Holzer U, Renner A-T, Valipour A. Effectiveness and efficacy of minimally invasive lung volume reduction surgery for emphysema. GMS Health Technol Assess 2014;10:Doc01.
 
Pfortmueller CA, Funk G-C, Leichtle AB, et al. Electrolyte Disorders and In-Hospital Mortality during Prolonged Heat Periods: A Cross-Sectional Analysis. PLoS One 2014;9(3):e92150.
 
Pfortmueller CA, Wiemann C, Funk G-C, et al. Hypoglycemia is associated with increased mortality in patients with acute decompensated liver cirrhosis. J Crit Care 2014;29(2):316.e7-316.e12.
 
Spruit MA, Pitta F, Garvey C, et al. Differences in content and organisational aspects of pulmonary rehabilitation programmes. Eur Respir J 2014;43(5):1326–37.
 
Urban MH, Valipour A, Kiss D, Eickhoff P, Funk GC, Burghuber OC. Soluble receptor of advanced glycation end-products and endothelial dysfunction in COPD. Respir Med 2014;108(6):891–7.
 
Urban MH, Ay L, Funk GC, et al. Insulin resistance may contribute to vascular dysfunction in patients with chronic obstructive pulmonary disease. Wien Klin Wochenschr 2014;126(3–4):106–12.
 
Valipour A, Herth FJF, Burghuber OC, et al. Target lobe volume reduction and COPD outcome measures after endobronchial valve therapy. Eur Respir J 2014;43(2):387–96.
 
Valipour A, Herth FJ, Eberhardt R, et al. Design of the randomized, controlled sequential staged treatment of emphysema with upper lobe predominance (STEP-UP) study. BMC Pulm Med 2014;14(1):190.
 
Vanfleteren LEGW, Kocks JWH, Stone IS, et al. Moving from the Oslerian paradigm to the postgenomic era: Are asthma and COPD outdated terms? Thorax 2014;69(1):72–9.
 
Arampatzis S, Funk G-C, Leichtle AB, et al. Impact of diuretic therapy-associated electrolyte disorders present on admission to the emergency department: a cross-sectional analysis. BMC Med 2013;11(1):83.
 
Arampatzis S, Gaetcke L-M, Funk G-C, et al. Diuretic-induced hyponatremia and osteoporotic fractures in patients admitted to the emergency department. Maturitas 2013;75(1):81–6.
 
Fazekas AS, Funk G-C, Klobassa DS, et al. Evaluation of 36 formulas for calculating plasma osmolality. Intensive Care Med 2013;39(2):302–8.
 
Firlinger I, Stubenberger E, Müller MR, Burghuber OC, Valipour A. Endoscopic One-Way Valve Implantation in Patients With Prolonged Air Leak and the Use of Digital Air Leak Monitoring. Ann Thorac Surg 2013;95(4):1243–9.
 
Funk GC, Bauer P, Burghuber OC, et al. Prevalence and prognosis of COPD in critically ill patients between 1998 and 2008. Eur Respir J 2013;41(4):792–9.
 
Gompelmann D, Eberhardt R, Ernst A, et al. The localized inflammatory response to bronchoscopic thermal vapor ablation. Respiration 2013;86(4):324–31.
 
Kneidinger N, Funk GC, Lindner G, Drolz A, Schenk P, Fuhrmann V. Unmeasured anions are associated with short-term mortality in patients with hypoxic hepatitis. Wien Klin Wochenschr 2013;125(15–16):474–80.
 
Lindner G, Pfortmueller CA, Funk G-C, Leichtle AB, Fiedler GM, Exadaktylos AK. High-Sensitive Troponin Measurement in Emergency Department Patients Presenting with Syncope: A Retrospective Analysis. PLoS One 2013;8(6):e66470.
 
Lindner G, Schwarz C, Grüssing H, Kneidinger N, Fazekas A, Funk G-C. Rising serum sodium levels are associated with a concurrent development of metabolic alkalosis in critically ill patients. Intensive Care Med 2013;39(3):399–405.
 
Lopez-Campos JL, Hartl S, Pozo-Rodriguez F, Roberts CM. European COPD Audit: Design, organisation of work and methodology. Eur Respir J 2013;41(2):270–6.
 
Pfortmueller CA, Funk GC, Marti G, et al. Diagnostic performance of high-sensitive troponin T in patients with renal insufficiency. Am J Cardiol 2013;112(12):1968–72.
 
Roberts CM, Lopez-Campos JL, Pozo-Rodriguez F, Hartl S. European hospital adherence to GOLD recommendations for chronic obstructive pulmonary disease (COPD) exacerbation admissions: Table 1. Thorax 2013;68(12):1169–71.
 
Arampatzis S, Frauchiger B, Fiedler G-M, et al. Characteristics, Symptoms, and Outcome of Severe Dysnatremias Present on Hospital Admission. Am J Med 2012;125(11):1125.e1-1125.e7.
 
Arampatzis S, Lindner G, Irmak F, Funk G-C, Zimmermann H, Exadaktylos AK. Geriatric urolithiasis in the emergency department: risk factors for hospitalisation and emergency management patterns of acute urolithiasis. BMC Nephrol 2012;13(1):117.
 
Breyer M-K, Rutten EPA, Spruit MA, Hop WCJ, Postma DS, Wouters EFM. Systemic Inflammation in Patients with Chronic Obstructive Pulmonary Disease: Results from the Cosmic Study. Open J Respir Dis 2012;02(03):63–72.
 
Breyer M-K, Rutten EPA, Locantore NW, Watkins ML, Miller BE, Wouters EFM. Dysregulated adipokine metabolism in chronic obstructive pulmonary disease. Eur J Clin Invest 2012;42(9):983–91.
 
Fazekas AS, Wewalka M, Zauner C, Funk G-C. Carboxyhemoglobin levels in medical intensive care patients: a retrospective, observational study. Crit Care 2012;16(1):R6.
 
Gompelmann D, Heussel CP, Eberhardt R, et al. Efficacy of bronchoscopic thermal vapor ablation and lobar fissure completeness in patients with heterogeneous emphysema. Respiration 2012;83(5):400–6.
 
Hartl S. The European COPD Audit: a pilot experience of 16 European countries. Pneumonol Alergol Pol 2012;80(6):501–4.
 
Herth FJF, Noppen M, Valipour A, et al. Efficacy predictors of lung volume reduction with Zephyr valves in a European cohort. Eur Respir J 2012;39(6):1334–42.
 
Herth FJ, KM B, Egan JJ, et al. Characterization of outcomes 1 year after endoscopic thermal vapor ablation for patients with heterogeneous emphysema. Int J Chron Obstruct Pulmon Dis 2012;7:397.
 
Lindner G, Schwarz C, Funk G-C. Osmotic diuresis due to urea as the cause of hypernatraemia in critically ill patients. Nephrol Dial Transplant 2012;27(3):962–7.
 
Magnussen H, Kramer MR, Kirsten A-M, et al. Effect of fissure integrity on lung volume reduction using a polymer sealant* in advanced emphysema. Thorax 2012;67(4):302–8.
 
Snell G, Herth FJF, Hopkins P, et al. Bronchoscopic thermal vapour ablation therapy in the management of heterogeneous emphysema. Eur Respir J 2012;39(6):1326–33.
 
Valipour A, Kramer MR, Stanzel F, et al. Physiological Modeling of Responses to Upper Versus Lower Lobe Lung Volume Reduction in Homogeneous Emphysema. Front Physiol 2012;3:387.
 
Breyer M-K, Rutten EPA, Vernooy JHJ, et al. Gender differences in the adipose secretome system in chronic obstructive pulmonary disease (COPD): A pivotal role of leptin. Respir Med 2011;105(7):1046–53.
 
Faybik P, Hetz H, Mitterer G, et al. Regional citrate anticoagulation in patients with liver failure supported by a molecular adsorbent recirculating system. Crit Care Med 2011;39(2):273–9.
 
Funk G-C, Breyer M-K, Burghuber OC, et al. Long-term non-invasive ventilation in COPD after acute-on-chronic respiratory failure. Respir Med 2011;105(3):427–34.
 
Locker GJ, Fuchs E-M, Worel N, et al. Whole Body Hyperthermia by Extracorporeal Circulation in Spontaneously Breathing Sarcoma Patients: Hemodynamics and Oxygen Metabolism. Int J Artif Organs 2011;34(11):1085–94.
 
Randerath WJ, Verbraecken J, Andreas S, et al. Non-CPAP therapies in obstructive sleep apnoea. Eur Respir J 2011;37(5):1000–28.
 
Valipour A, Lavie P, Lothaller H, Mikulic I, Burghuber OC. Sleep profile and symptoms of sleep disorders in patients with stable mild to moderate chronic obstructive pulmonary disease. Sleep Med 2011;12(4):367–72.
 
Breyer M-K, Breyer-Kohansal R, Funk G-C, et al. Nordic Walking improves daily physical activities in COPD: a randomised controlled trial. Respir Res 2010;11(1):112.
 
Eickelberg O, Laurent G, Nicod LP, Hartl S, Siafakas NM. European Respiratory Society MD PhD programme in respiratory science. Eur Respir J 2010;36(2):229–30.
 
Funk G-C, Anders S, Breyer M-K, et al. Incidence and outcome of weaning from mechanical ventilation according to new categories. Eur Respir J 2010;35(1):88–94.
 
Lindner G, Funk G-C, Lassnigg A, et al. Intensive care-acquired hypernatremia after major cardiothoracic surgery is associated with increased mortality. Intensive Care Med 2010;36(10):1718–23.
 
Rutten EPA, Breyer MK, Spruit MA, et al. Abdominal fat mass contributes to the systemic inflammation in chronic obstructive pulmonary disease. Clin Nutr 2010;29(6):756–60.
 
Walch A, Meshkat M, Vogelsang H, et al. Long-term outcome in patients with ulcerative colitis treated with intravenous cyclosporine A is determined by previous exposure to thiopurines. J Crohn’s Colitis 2010;4(4):398–404.
 
Breyer M-K, Spruit MA, Celis APM, Rutten EPA, Janssen PP, Wouters EFM. Highly elevated C-reactive protein levels in obese patients with COPD: A fat chance? Clin Nutr 2009;28(6):642–7.
 
Cekici L, Valipour A, Kohansal R, Burghuber OC. Short-term effects of inhaled salbutamol on autonomic cardiovascular control in healthy subjects: a placebo-controlled study. Br J Clin Pharmacol 2009;67(4):394–402.
 
Funk G-C, Kirchheiner K, Chris Burghuber O, Hartl S. BODE index versus GOLD classification for explaining anxious and depressive symptoms in patients with COPD – a cross-sectional study. Respir Res 2009;10(1):1.
 
Kaufmann M, Hartl S, Geyer K, Breyer MK, Burghuber OC. Measuring FEV6 for detecting early airway obstruction in the primary care setting. Respiration 2009;78(2):161–7.
 
Kohansal R, Martinez-Camblor P, Agustí A, Buist AS, Mannino DM, Soriano JB. The Natural History of Chronic Airflow Obstruction Revisited. Am J Respir Crit Care Med 2009;180(1):3–10.
 
Kohansal R, Soriano JB, Agusti A. Investigating the Natural History of Lung Function: facts, pitfalls, and opportunities. Chest 2009;135(5):1330–41.
 
Oschatz E, Prosch H, Kohansal R, Valipour A, Mostbeck G. COPD and Osteoporosis: Detection and Grading of Vertebral Fractures on Lateral Chest Radiography. J Thorac Imaging 2009;24(3):212–5.
 
Pitta F, Breyer MK, Hernandes NA, et al. Comparison of daily physical activity between COPD patients from Central Europe and South America. Respir Med 2009;103(3):421–6.
 
Zwick RH, Burghuber OC, Dovjak N, et al. Der Effekt von einem Jahr ambulanter pneumologischer Rehabilitation auf Patienten mit COPD. Wien Klin Wochenschr 2009;121(5–6):189–95.
 
Eickhoff P, Valipour A, Kiss D, et al. Determinants of Systemic Vascular Function in Patients with Stable Chronic Obstructive Pulmonary Disease. Am J Respir Crit Care Med 2008;178(12):1211–8.
 
Funk G-C, Lang I, Schenk P, Valipour A, Hartl S, Burghuber OC. Left Ventricular Diastolic Dysfunction in Patients With COPD in the Presence and Absence of Elevated Pulmonary Arterial Pressure. Chest 2008;133(6):1354–9.
 
Valipour, Arschang, Ruis M, Burghuber OC. Journal für Hypertonie. J für Hypertonie 2008;12(2):31–3.
 
Valipour A, Schreder M, Wolzt M, et al. Circulating vascular endothelial growth factor and systemic inflammatory markers in patients with stable and exacerbated chronic obstructive pulmonary disease. Clin Sci 2008;115(7):225–32.
 
Vonbank K, Funk GC, Marzluf B, et al. Abnormal pulmonary arterial pressure limits exercise capacity in patients with COPD. Wien Klin Wochenschr 2008;120(23–24):749–55.
 
Eisenburger P, Funk GC, Burda G, Sterz FR, Laggner AN, Herkner H. Gas concentrations in expired air during basic life support using different ratios of compression to ventilation. Resuscitation 2007;73(1):115–22.
 
Holzinger U, Kitzberger R, Fuhrmann V, Funk GC, Madl C, Ratheiser K. Correlation of calculated indices of insulin resistance (QUICKI and HOMA) with the euglycaemic hyperinsulinaemic clamp technique for evaluating insulin resistance in critically ill patients. Eur J Anaesthesiol 2007;24(11):966–70.
 
Kneidinger N, Lindner G, Fuhrmann V, et al. Acute phase proteins do not account for unmeasured anions in critical illness. Eur J Clin Invest 2007;37(10):820–5.
 
Lindner G, Funk GC, Schwarz C, et al. Hypernatremia in the Critically Ill Is an Independent Risk Factor for Mortality. Am J Kidney Dis 2007;50(6):952–7.
 
Nava S, Sturani C, Hartl S, et al. End-of-life decision-making in respiratory intermediate care units: A European survey. Eur Respir J 2007;30(1):156–64.
 
Valipour A, Lothaller H, Rauscher H, Zwick H, Burghuber OC, Lavie P. Gender-related differences in symptoms of patients with suspected breathing disorders in sleep: A clinical population study using the Sleep Disorders Questionnaire. Sleep 2007;30(3):312–9.
 
Fuhrmann V, Madl C, Mueller C, et al. Hepatopulmonary Syndrome in Patients With Hypoxic Hepatitis. Gastroenterology 2006;131(1):69–75.
 
Kramer L, Hofer H, Bauer E, et al. Relative impact of fatigue and subclinical cognitive brain dysfunction on health-related quality of life in chronic hepatitis C infection. AIDS 2005;19(Suppl 3):S85–92.
 
Prebio M, Katz-Papatheophilou E, Heindl W, Gelbmann H, Burghuber OC. Verminderung von hautdefekten bei bauchlagerung bei beatmeten intensivpatienten durch das prone-head-support-system: Eine pilotstudie. Wien Klin Wochenschr 2005;117(3):98–105.
 
Valipour A, Kreuzer A, Koller H, Koessler W, Burghuber OC. Bronchoscopy-Guided Topical Hemostatic Tamponade Therapy for the Management of Life-Threatening Hemoptysis. Chest 2005;127(6):2113–8.
 
Valipour A, Schneider F, Kössler W, Saliba S, Burghuber OC. Heart rate variability and spontaneous baroreflex sequences in supine healthy volunteers subjected to nasal positive airway pressure. J Appl Physiol 2005;99(6):2137–43.
 
Alt E, Amann-Vesti BR, Madl C, Funk G, Koppensteiner R. Platelet aggregation and blood rheology in severe sepsis/septic shock: relation to the Sepsis-related Organ Failure Assessment (SOFA) score. Clin Hemorheol Microcirc 2004;30(2):107–15.
 
Hartl S, Heindl W, Lahrmann H, et al. Provisions for long-term at home ventilated patient: consensus recommendations of the Austrian Society for Lung Diseases and Tuberculosis. Wien Klin Wochenschr 2004;116 Suppl(3):1–20.
 
Valipour A, Cozzarini W, Burghuber OC. Non-Invasive Pressure Support Ventilation in Patients with Respiratory Failure due to Severe Acute Cardiogenic Pulmonary Edema. Respiration 2004;71(2):144–51.
 
Valipour A, Litschauer B, Mittermayer F, Rauscher H, Burghuber OC, Wolzt M. Circulating plasma levels of vascular endothelial growth factor in patients with sleep disordered breathing. Respir Med 2004;98(12):1180–6.
 
Bauer E, Funk G-C, Gendo A, et al. Electropyhsiological assessment of the afferent sensory pathway in cardiac arrest survivors. Eur J Clin Invest 2003;33(4):283–7.
 
McGown AD, Makker H, Elwell C, Rawi PG Al, Valipour A, Spiro SG. Measurement of Changes in Cytochrome Oxidase Redox State During Obstructive Sleep Apnea Using Near-Infrared Spectroscopy. Sleep 2003;26(6):710–6.
 
Petkov V, Mosgoeller W, Ziesche R, et al. Vasoactive intestinal peptide as a new drug for treatment of primary pulmonary hypertension. J Clin Invest 2003;111(9):1339–46.
 
Stiebellehner L, Petkov V, Vonbank K, et al. Long-term Treatment With Oral Sildenafil in Addition to Continuous IV Epoprostenol in Patients With Pulmonary Arterial Hypertension. Chest 2003;123(4):1293–5.